|
DeGiorgio, Lorraine A; Manuelidis, Laura; Bernstein, Jerald J (2002) Transient appearance of amyloid precursor protein plaques in the brain of thymectomized rats after human leptomeningeal cell grafts. Neurosci Lett 322:62-6
|
|
Behar, K L; Boucher, R; Fritch, W et al. (1998) Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease. Magn Reson Imaging 16:963-8
|
|
Manuelidis, L (1994) The dimensions of Creutzfeldt-Jakob disease. Transfusion 34:915-28
|
|
Sklaviadis, T; Dreyer, R; Manuelidis, L (1992) Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation. Virus Res 26:241-54
|
|
Taruscio, D; Manuelidis, L (1991) Integration site preferences of endogenous retroviruses. Chromosoma 101:141-56
|
|
Manuelidis, E E; Manuelidis, L (1991) Search for a transmissible agent in Alzheimer's disease: studies of human buffy coat. Curr Top Microbiol Immunol 172:275-80
|
|
Akowitz, A; Sklaviadis, T; Manuelidis, E E et al. (1990) Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations. Microb Pathog 9:33-45
|
|
Murdoch, G H; Sklaviadis, T; Manuelidis, E E et al. (1990) Potential retroviral RNAs in Creutzfeldt-Jakob disease. J Virol 64:1477-86
|
|
Sklaviadis, T; Akowitz, A; Manuelidis, E E et al. (1990) Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes. Arch Virol 112:215-28
|
|
Sklaviadis, T K; Manuelidis, L; Manuelidis, E E (1989) Physical properties of the Creutzfeldt-Jakob disease agent. J Virol 63:1212-22
|
Showing the most recent 10 out of 31 publications
